Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ResMed Inc (NYSE:RMD)

58.22
Delayed Data
As of 4:02pm ET
 +0.50 / +0.87%
Today’s Change
48.99
Today|||52-Week Range
61.23
+8.44%
Year-to-Date
ResMed: Positive CAT-HF Study Results to Drive ASV Sales
May 25 / Zacks.com - Paid Partner Content
High Quality Guru Stocks: EMC, Bed Bath & Beyond
May 24 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close57.72
Today’s open57.72
Day’s range57.61 - 58.38
Volume554,096
Average volume (3 months)1,105,186
Market cap$8.1B
Dividend yield2.06%
Data as of 4:02pm ET, 05/26/2016

Growth & Valuation

Earnings growth (last year)+3.35%
Earnings growth (this year)+1.64%
Earnings growth (next 5 years)+10.70%
Revenue growth (last year)+7.97%
P/E ratio23.8
Price/Sales4.79
Price/Book5.11

Competitors

 Today’s
change
Today’s
% change
VARVarian Medical Syste...-0.70-0.85%
TFXTeleflex Inc-0.74-0.46%
CMNCantel Medical Corp+0.62+0.94%
LIVNLivaNova PLC+0.04+0.08%
Data as of 4:02pm ET, 05/26/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.74
Annual revenue (last year)$1.7B
Annual profit (last year)$352.9M
Net profit margin21.02%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Mick Farrell
President &
Chief Operating Officer
Robert Andrew Douglas
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs